🌟 Tesamorelin – 10mg Lyophilized Peptide Powder 🌟
Strength: 10mg
Form: Lyophilized powder (must be dissolved before injection)
Intended Use: Health supplement for injection
🧬 Product Overview
PrimeLab Tesamorelin is a high-purity lyophilized peptide powder administered via subcutaneous injection. It supports the body’s natural hormone regulation, enhances metabolic efficiency, and promotes muscle and tissue health, leaving you feeling more energized✨.
🌱 Key Ingredients
Tesamorelin Active Peptide (10mg)
Promotes natural hormonal balance and metabolic efficiency⚡
Lyophilized Powder Form
For injection; peptides are rapidly absorbed💧
💖 Effects on the Body
Boosts Energy and Vitality ⚡
Supports daily energy levels, enhancing endurance and vitality.
Promotes Tissue Repair and Muscle Health 💪
Supports muscle and soft tissue recovery, accelerating repair after workouts or daily activities.
Improves Metabolic Efficiency 🔄
Promotes the body’s efficient utilization of nutrients and energy, enhancing overall metabolic capacity.
Supports Physical Endurance and Energy Recovery ⚡
Reduces recovery time from fatigue, helping the body cope more easily with daily life.
Overall Health Support ❤️
Assists in the balanced functioning of bodily systems, maintaining long-term health.
💉 Usage Recommendations (Injection)
Dissolve the lyophilized powder according to the instructions and administer via subcutaneous injection.
Use daily at the recommended dosage; best results are achieved when combined with a healthy diet and exercise.
It is recommended to rotate injection sites (abdomen, outer thigh, or outer upper arm) to maintain skin health.
Tesamorelin 10mg is a laboratory research peptide used to study GHRH receptor signaling, pituitary response behavior, and downstream endocrine pathway activity in controlled experimental systems. This product is supplied strictly for research use only.
preclinical or in vitro research.
Tesamorelin 10mg supplied for research purposes is manufactured to meet high analytical standards. It is typically provided as a high-purity, LPS-free peptide, verified as an endotoxin-free peptide, and classified under research peptides endotoxin tested protocols. These quality attributes support reproducibility, consistency, and integrity across experimental and laboratory investigations.
Reconstitution Guide
Standard reconstitution protocol for lyophilized Tesamorelin 10mg using bacteriostatic water.
[1]
Prepare Aseptic Environment
Ensure all equipment is sterile. Work under aseptic conditions — laminar flow hood preferred. Swab both vial stoppers with 70% isopropyl alcohol and allow to fully air-dry before puncturing.
[2]
Reconstitute with BAC Water
Using a sterile syringe, draw the calculated volume of bacteriostatic water. Inject slowly into the Tesamorelin 10mg vial along the glass wall. Do not shake. Gently swirl until fully dissolved.
[3]
Store and Document
Reconstituted Tesamorelin 10mg should be stored at 2–8°C and used within 28 days. Discard immediately if cloudiness or particulates appear. Unopened lyophilized vials remain stable at -20°C for up to 24 months.
Endotoxin Note: Tesamorelin 10mg is endotoxin-screened at the compound level. Full LAL test results available in the product COA.
Vendor Comparison
Why Researchers Choose Licensed Peptides
Not all peptide vendors hold themselves to the same verification standards.
Frequently Asked Questions
Tesamorelin is a synthetic GHRH analogue used in laboratory research to study endogenous growth hormone regulation, IGF-1 signaling, and visceral adipose tissue dynamics in experimental systems. It is not approved for general use.
It binds to GHRH receptors in the anterior pituitary and is used in laboratory studies to examine endocrine signaling behavior. This description is provided for research context only and does not imply therapeutic or clinical use.
Researchers study tesamorelin because the compound is used in models involving GH/IGF-1 signaling and visceral adipose tissue behavior. Any mention of visceral fat is limited to published research context.
No. Tesamorelin is studied as a GHRH analogue, while growth hormone is a different hormone. This distinction is relevant to experimental design and does not indicate medical use.
Study timelines vary by protocol and model. Any timing references in the literature are provided for research context only and are not product performance claims.
Tesamorelin is not considered an anabolic agent. Any muscle-related findings discussed in the literature are reported within research contexts
Published studies may examine whether certain experimental outcomes persist or change after exposure ends. This is research context only and does not imply therapeutic benefit.
Published research may report tolerability observations under defined study conditions. These observations are included for scientific context only and do not indicate approval for human or veterinary use.
Some research models examine insulin-related markers in relation to GH/IGF-1 and visceral adipose tissue pathways. This is research context only and does not imply clinical benefit.
Tesamorelin is studied for its receptor-mediated signaling profile and downstream endocrine response behavior. Timing observations are model-dependent and are included only for research context.
Tesamorelin is studied as a GHRH analogue with specific relevance to GH/IGF-1 signaling and visceral adipose tissue research models. This is descriptive research context only.
An LPS-free peptide indicates that the material has been tested to ensure the absence of lipopolysaccharides, which are bacterial endotoxins that could interfere with experimental outcomes in sensitive research assays.
Being an endotoxin-free peptide means the product meets strict endotoxin limits, supporting accuracy and reliability in laboratory and investigative research where endotoxin contamination could compromise data integrity.